Eli Lilly and Company (NYSE: LLY) announced today it will present Phase 3 data for galcanezumab and lasmiditan, two investigational, non-opioid treatments for migraine and cluster …
Preliminary data from the first clinical trial of the company’s intracranial ultrasound implant, SonoCloud®, show a good safety profile and promising trends in overall survival …
When: 03 – 04 July, 2018 Where: Radisson Blu Hotel, Zurich Airport The only event for senior Clinical Operations and Procurement professionals driving innovation in …
For people with chronic or incurable conditions, there’s only one thing scarier than the experimental treatments involved in a clinical trial — getting the placebo. …
Streamline & Innovate Clinical Trials Operations Against A Backdrop of Shifting Priorities and Political Change The 5th Annual Outsourcing in Clinical Trials UK & Ireland …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
